• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol J . Burden and characteristics of Respiratory Syncytial Virus-associated respiratory tract infections in adult patients in the winter season 2

tetano

Editor, Senior Moderator
Virol J


. 2025 Mar 17;22(1):76.
doi: 10.1186/s12985-025-02692-z. Burden and characteristics of Respiratory Syncytial Virus-associated respiratory tract infections in adult patients in the winter season 2023/2024 at the conservative emergency department of the university hospital in Dresden

J Ronczka[SUP] 1 2 [/SUP], S von Bonin[SUP] 3 [/SUP], A Laubner[SUP] 4 [/SUP], K Hochauf-Stange[SUP] 4 [/SUP], M Rank[SUP] 5 [/SUP], M Kolditz[SUP] 6 7 [/SUP]



Affiliations
Abstract

Introduction: The burden of Respiratory Syncytial Virus (RSV) associated adult emergency department visits in comparison to other respiratory viruses like Influenza and SARS-CoV-2 remains less studied.
Methods: We performed a prospective observational study to describe prevalence, severity and risk factors of RSV infection, proven by polymerase chain reaction from nasopharyngeal or pharyngeal swabs, in consecutive adult patients presenting to the emergency ward of the University Hospital Dresden with a working diagnosis of acute respiratory tract infection during the winter season between October 1st 2023 and April 15th 2024.
Results: 1764 adults (56.3% male) between 18 and 101 years old (median age 69 years) were included in the analysis. 477 patients (27.1%) tested positive for viral infection; 284 (16.2%) with SARS-CoV-2 (median age 79 years), 147 (8.4%) with Influenza A or B (median age 56 years) and 38 (2.2%) with RSV A or B (median age 79 years). In 8 patients (0.5%) a co-infection with two viruses was detected. In the RSV cohort any oxygen support was significantly higher (63.2%) compared to the Influenza (34.0%, p < 0.001) and SARS-CoV-2 (41.5%, p = 0.012) cohorts. In-hospital mortality was considerable especially for RSV with 7.9% compared to Influenza (2.7%, p = 0.138) and SARS-CoV-2 (5.6%, p = 0.580).
Conclusion: RSV was less frequent in adults presenting to the emergency department during the 2023/24 season compared to SARS-CoV-2 and Influenza, but patients needed a higher level of respiratory support. Also, in-hospital mortality was considerable, making RSV-infections a relevant pathogen in adult patients presenting with respiratory tract infection to an emergency department.

Keywords: Adults; Comorbidities; RSV; Respiratory tract infections; Risk.

 
Back
Top Bottom